Loading
Latest filing published 20 Aug 2026 for Genix Pharmaceuticals Corporation.
No signal scores available.
This profile gathers the share dealings of Kevin Bottomley in Genix Pharmaceuticals Corporation. The record holds 2 filings, for trades running from 19 March 2021 to 19 March 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 20 August 2026 came the latest disclosure, an option exercise in Genix Pharmaceuticals Corporation. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations